MPAM
BEAT

Monarch Partners Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Monarch Partners Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,620
Closed -$350K – 220
2017
Q3 		$350K Sell
10,620
-188,140
-95% -$6.52M 0.03% 169
2017
Q2 		$6.65M Buy
+198,760
New +$5.93M 0.66% 66

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Monarch Partners Asset Management's BEAT Position: Q4 2017 in Review

Monarch Partners Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 10,620 shares — an estimated $350K sold.

Monarch Partners Asset Management first reported a position in BEAT in Q2 2017 and held it in 2 quarters. The position peaked at $6.65M in Q2 2017. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

  • Monarch Partners Asset Management reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
  • Monarch Partners Asset Management sold 10,620 BioTelemetry, Inc. shares in Q4 2017, an estimated $350K.
  • Monarch Partners Asset Management first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 2 quarters.
  • Monarch Partners Asset Management's BioTelemetry, Inc. position peaked at $6.65M in Q2 2017.
  • 192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on Monarch Partners Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.